Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
Demographics (3)
- AGE - Subject age at time of surgery (phv00528015.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00528022.v1.p1)
- SEX - Biological sex (phv00528010.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00528016.v1.p1)
Other (15)
- AFFECTION_STATUS - Case control status of the subject for neuroendocrine tumor (NET); all subjects are NET patients. (phv00528014.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00528019.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00528018.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00528009.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00528021.v1.p1)
- IS_TUMOR - Tumor status (phv00528020.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00528023.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00528024.v1.p1)
- SAMPLE_ID - Sample ID (phv00528017.v1.p1)
- SAMPLE_ID - Sample ID (phv00528012.v1.p1)
- SUBJECT_ID - Subject ID (phv00528013.v1.p1)
- SUBJECT_ID - Subject ID (phv00528008.v1.p1)
- SUBJECT_ID - Subject ID (phv00528011.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00528025.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00528026.v1.p1)